- Biohaven looks to take on Lilly in the muscle-sparing obesity spaceThey say that the way to make money in a gold rush is to open a shop selling picks and shovels. By the same token, perhaps companies can profit from the GLP-1 boom by developing ...Endpoints · 17d ago↗ source
- Sino Biopharm hooks AstraZeneca, GSK for separate respiratory partnershipsSino Biopharmaceutical announced drug development and sales pacts with two UK pharma companies on Wednesday. One will see the Hong Kong biotech license an investigational PDE3/4 inhibitor to Astr…Endpoints · 17d ago↗ source
- Satellos gives early look at Duchenne pill in adults ahead of key data in childrenSatellos Bioscience is building its case for a Duchenne muscular dystrophy pill with data in adult patients ahead of a potentially pivotal readout in children later this year. The Canadian biotec…